Intellicell Biosciences, Inc. Convertible Notes Payable
Intellicell Biosciences, Inc. had Convertible Notes Payable of $1.93 million as of 2014-06-30, per its 10-Q filed 2014-10-10.
Discontinued › Balance Sheet › Liabilities › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2014-10-10
- 2014-06-30: Convertible Notes Payable $1.93M.
- 2013-12-31: Convertible Notes Payable $2.76M; Convertible Notes Payable as first filed $3.51M.
- 2013-09-30: Convertible Notes Payable $575.00K.
- 2013-06-30: Convertible Notes Payable $530.00K.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2014-06-30 | $1.93M 10-Q · filed 2014-10-10 | |
| 2013-12-31 | $2.76M 10-Q · filed 2014-10-10 | $3.51M 10-K · filed 2014-05-12 |
| 2013-09-30 | $575.00K 10-Q · filed 2014-10-08 | |
| 2013-06-30 | $530.00K 10-Q/A · filed 2013-10-18 | |
| 2012-12-31 | $699.17K 10-K · filed 2014-10-09 | $515.00K 10-Q · filed 2013-10-03 |